Program Operations Manual System (POMS)
TN 38 (09-20)
COMPASSIONATE ALLOWANCES INFORMATION
|
ANGELMAN
SYNDROME |
ALTERNATE NAMES
|
AS
|
DESCRIPTION
|
Angelman Syndrome (AS) is a rare genetic neurological disorder that involves a deletion of chromosome 15q
and mutation of the UBE3A gene. It is characterized by developmental delay, intellectual
disability, and severe speech impairment with a limited vocabulary (usually consisting
of less than 10 words). Some children with this disorder experience recurrent seizures
varying from major motor to a sudden brief lapse in muscle tone (akinetic).
Children with AS are described as generally happy with an excitable demeanor and frequent
smiling, laughter, and hand-flapping movements. Hyperactivity and a short attention
span are common. Developmental delays become noticeable by age 6 to 12 months, and
seizures generally begin between 2 and 3 years of age. Many children with AS also
have difficulty sleeping.
|
DIAGNOSTIC TESTING, PHYSICAL FINDINGS, AND
ICD-9-CM/ICD-10-CM
CODING
|
Diagnostic testing: The diagnosis of AS is established by a combination of clinical features and molecular
genetic testing and/or fluorescent in situ hybridization (FISH) analysis.
Physical findings: Physical symptoms include:
-
•
Small head size (microcephaly);
-
•
Hypotonia (reduced muscle strength);
-
•
Scoliosis (curved or crooked spine);
-
•
Ataxia (difficulties with coordination, balance and spasticity); and
-
ICD-9: 759.89
ICD-10: Q93.51
|
PROGRESSION
|
People with AS may survive into adulthood but continue to have severe cognitive and
communication impairments. The intensity and frequency of seizures tends to subside
with age.
|
TREATMENT
|
There is currently no cure for this disorder. Management of AS includes treatment
of seizures, physical and occupational therapies to improve adaptive functioning,
and speech therapy with a focus on non-verbal methods of communication. School age
children require individualized and flexible instructional curricula.
|
SUGGESTED PROGRAMMATIC
ASSESSMENT* |
Suggested MER for Evaluation:
-
•
Clinical examination that describes diagnostic features of the impairment and laboratory
findings are needed to confirm the diagnosis.
-
•
Developmental assessment or psychological testing to address allegations of mental
impairment may be warranted.
|
Suggested Listings for
Evaluation: |
DETERMINATION |
LISTING |
REMARKS |
Meets |
12.05 |
AS involves multiple body systems. A description of clinical and laboratory findings
will be needed to adjudicate these cases.
|
110.08 B
|
AS involves multiple body systems. A description of clinical and laboratory findings
will be needed to adjudicate these cases.
|
112.05
|
AS involves multiple body systems. A description of clinical and laboratory findings
will be needed to adjudicate these cases.
|
Equals |
|
|
* Adjudicators may, at their discretion, use the Medical Evidence of Record or the
listings suggested to evaluate the claim. However, the decision to allow or deny the
claim rests with the adjudicator.
|